Two of their standout formulations include: Liposomal BPC-157 + KPV targets gut integrity, inflammation modulation, and connective tissue support
Indeed, BPC 157 use has not been approved by the US Food and Drug Administration, meaning that it cannot legally be prescribed or purchased in the USA
The compound has been extensively studied for its effects on angiogenesis, tendon and ligament repair, gastrointestinal mucosal protection, and modulation of the nitric oxide (NO) pathway
As is evidenced in the figure, treatment with the INK inhibitor formulation dramatically reduced the ABR threshold shift at various frequencies
At Next Health, we look for optimal levels and value the incremental 1% improvements in your data over time